연구성과로 돌아가기

2020 연구성과별 연구자 정보 (1775 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Kim, Eun Young Kim, EY 10 Catholic Univ, Dept Internal Med, Daegu Sch Med, Daegu, South Korea JCE-3602-2023 Kim, Eun Young 0000-0003-3965-9964 Kim, Eun Young jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Jung, Yun Jin Jung, YJ 11 Daegu Fatima Hosp, Dept Internal Med, Daegu, South Korea jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Park, Soo-Kyung Park, SK 12 Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Gastroenterol,Sch Med, Seoul, South Korea jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Park, Dong Il Park, DI 13 Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Gastroenterol,Sch Med, Seoul, South Korea jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Ye, Byong Duk Ye, BD 14 Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea AAF-4955-2020 Ye, Byong jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Jung, Sung-Ae Jung, SA 15 교신저자 Ewha Womans Univ, Dept Internal Med, Sch Med, 260 Gonghangdae Ro, Seoul 07804, South Korea jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease Yang, Suk-Kyun Yang, SK 16 교신저자 Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea jassa@ewha.ac.kr;sky@amc.seoul.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Kim, Kyoung-Tae Kim, KT 1 Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Daegu 41944, South Korea 0000-0003-4867-6854 Kim, Kyoung-Tae nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Kim, Kyoung-Tae Kim, KT 1 Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu 41566, South Korea 0000-0003-4867-6854 Kim, Kyoung-Tae nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Kim, Kwang Gi Kim, KG 2 Gachon Univ, Coll Med, Dept Biomed Engn, Seongnam Si 13120, South Korea D-6890-2012 kim, kwanggi 0000-0001-9714-6038 Kim, Kwang Gi nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Kim, Kwang Gi Kim, KG 2 Gachon Univ, Dept Hlth Sci & Technol, Gachon Adv Inst Hlth Sci & Technol GAIHST, Seongnam Si 13120, South Korea D-6890-2012 kim, kwanggi 0000-0001-9714-6038 Kim, Kwang Gi nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Choi, Un Yong Choi, UY 3 CHA Univ, CHA Bundang Med Ctr, Dept Neurosurg, Seongnam Si 13496, South Korea nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Lim, Sang Heon Lim, SH 4 Gachon Univ, Coll Med, Dept Biomed Engn, Seongnam Si 13120, South Korea 0000-0002-1298-5180 Lim, Sang Heon nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Lim, Sang Heon Lim, SH 4 Gachon Univ, Dept Hlth Sci & Technol, Gachon Adv Inst Hlth Sci & Technol GAIHST, Seongnam Si 13120, South Korea 0000-0002-1298-5180 Lim, Sang Heon nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial Kim, Young Jae Kim, YJ 5 Gachon Univ, Coll Med, Dept Biomed Engn, Seongnam Si 13120, South Korea 0000-0003-0443-0051 Kim, Young Jae nskimkt7@gmail.com;kimkg@gachon.ac.kr;nschoiuy@gmail.com;smion123@naver.com;youngjae@gachon.ac.kr;sisohn@hanmail.net;nssheen@gmail.com;lionheo@gmail.com;hanib@cha.ac.kr;
페이지 이동: